Dynamic Microsimulation Models for Health Outcomes

Background. Microsimulation models (MSMs) for health outcomes simulate individual event histories associated with key components of a disease process; these simulated life histories can be aggregated to estimate population-level effects of treatment on disease outcomes and the comparative effectiveness of treatments. Although MSMs are used to address a wide range of research questions, methodological improvements in MSM approaches have been slowed by the lack of communication among modelers. In addition, there are few resources to guide individuals who may wish to use MSM projections to inform decisions. Methods. This article presents an overview of microsimulation modeling, focusing on the development and application of MSMs for health policy questions. The authors discuss MSM goals, overall components of MSMs, methods for selecting MSM parameters to reproduce observed or expected results (calibration), methods for MSM checking (validation), and issues related to reporting and interpreting MSM findings(sensitivity analyses, reporting of variability, and model transparency). Conclusions. MSMs are increasingly being used to provide information to guide health policy decisions. This increased use brings with it the need for both better understanding of MSMs by policy researchers, and continued improvement in methods for developing and applying MSMs.

[1]  A Tsodikov,et al.  A population model of prostate cancer incidence , 2006, Statistics in medicine.

[2]  G. Friedman,et al.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.

[3]  Ruth Etzioni,et al.  Simulation modeling of outcomes and cost effectiveness. , 2000, Hematology/oncology clinics of North America.

[4]  J D Habbema,et al.  Model building on the basis of Dutch cervical cancer screening data. , 1985, Maturitas.

[5]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[6]  M. Zelen,et al.  Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution. , 2005, Biostatistics.

[7]  Nanda Piersma,et al.  Estimating Parameters of a Microsimulation Model for Breast Cancer Screening Using the Score Function Method , 2000, Ann. Oper. Res..

[8]  G. Orcutt,et al.  A new type of socio-economic system , 1957 .

[9]  O S Miettinen,et al.  Early lung cancer action project: a summary of the findings on baseline screening. , 2001, The oncologist.

[10]  Marvin Zelen,et al.  Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer , 1998 .

[11]  E Ackerman,et al.  Simulation of stochastic micropopulation models--I. The SUMMERS simulation shell. , 1993, Computers in biology and medicine.

[12]  Joshua M. Epstein,et al.  Containing a large bioterrorist smallpox attack: a computer simulation approach. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  David J. Vanness,et al.  The need for microsimulation to evaluate osteoporosis interventions , 2005, Osteoporosis International.

[14]  E Ackerman,et al.  Simulation of stochastic micropopulation models--II. VESPERS: epidemiological model implementations for spread of viral infections. , 1993, Computers in biology and medicine.

[15]  D. McGee,et al.  Prospective study of the frequency and size distribution of polyps missed by colonoscopy. , 1990, Journal of the National Cancer Institute.

[16]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[17]  J. Peters,et al.  Evaluating the performance of the Framingham risk equations in a population with diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[18]  S. Pauker,et al.  The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

[19]  Ping Zhang,et al.  Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[20]  J D Habbema,et al.  The MISCAN simulation program for the evaluation of screening for disease. , 1985, Computer methods and programs in biomedicine.

[21]  Brian W. Hollocks,et al.  Forty years of discrete-event simulation—a personal reflection , 2006, J. Oper. Res. Soc..

[22]  A J Palmer,et al.  The Mt. Hood challenge: cross-testing two diabetes simulation models. , 2000, Diabetes research and clinical practice.

[23]  Robert C. Lee,et al.  The Need for Evolution in Healthcare Decision Modeling , 2003, Medical Care.

[24]  E. Feuer,et al.  The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing , 2004, Statistical methods in medical research.

[25]  J. Griffiths The Theory of Stochastic Processes , 1967 .

[26]  Kara M. Kockelman,et al.  From Aggregate Methods to Microsimulation , 2007 .

[27]  L. Goldman,et al.  Cost-effectiveness of routine coronary angiography after acute myocardial infarction. , 1996, Circulation.

[28]  J D Habbema,et al.  A model for breast cancer screening , 1990, Cancer.

[29]  D. Rex,et al.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.

[30]  C. Earle,et al.  Economic decision analysis model of screening for lung cancer. , 2001, European journal of cancer.

[31]  Simon G Thompson,et al.  Accounting for uncertainty in health economic decision models by using model averaging , 2009, Journal of the Royal Statistical Society. Series A,.

[32]  R. Klein,et al.  A Bayesian approach to modelling the natural history of a chronic condition from observations with intervention. , 1999, Statistics in medicine.

[33]  E W Steyerberg,et al.  Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation , 2004, Heart.

[34]  Rob Boer,et al.  The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..

[35]  Randall P. Sadowski,et al.  Simulation with Arena , 1998 .

[36]  J D Habbema,et al.  Epidemiological modelling for onchocerciasis control. , 1992, Parasitology today.

[37]  G. Koëter,et al.  Simulated waiting list prioritization for equitable allocation of donor lungs. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[38]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .

[39]  E Goyder,et al.  A review and critique of modelling in prioritising and designing screening programmes. , 2007, Health technology assessment.

[40]  Ann G Zauber,et al.  National Polyp Study data: Evidence for regression of adenomas , 2004, International journal of cancer.

[41]  David M Eddy,et al.  Accuracy versus transparency in pharmacoeconomic modelling: finding the right balance. , 2006, PharmacoEconomics.

[42]  M. Zelen,et al.  Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding , 1999 .

[43]  S. Dewilde,et al.  The Cost-Effectiveness of Screening Programs Using Single and Multiple Birth Cohort Simulations: A Comparison Using a Model of Cervical Cancer , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[44]  M. Tockman,et al.  Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. , 2002, Chest.

[45]  Marek Ancukiewicz,et al.  Decision Models in Clinical Recommendations Development : the Stroke Prevention Policy , 1996 .

[46]  Martina Morris,et al.  Mathematical Models for HIV Transmission Dynamics: Tools for Social and Behavioral Science Research , 2008, Journal of acquired immune deficiency syndromes.

[47]  Robert L Kane,et al.  Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. , 2007, JAMA.

[48]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[49]  M. Kimmel,et al.  The natural history of lung cancer in a periodically screened population. , 1987, Biometrics.

[50]  M. Rosenberg Competing risks to breast cancer mortality. , 2006, Journal of the National Cancer Institute. Monographs.

[51]  L. Vale,et al.  The Value of Myocardial Perfusion Scintigraphy in the Diagnosis and Management of Angina and Myocardial Infarction: A Probabilistic Economic Analysis , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[52]  Leigh Tesfatsion,et al.  Handbook of Computational Economics, Volume 2: Agent-Based Computational Economics (Handbook of Computational Economics) , 2006 .

[53]  Dr David M. Eddy Accuracy versus Transparency in Pharmacoeconomic Modelling , 2012, PharmacoEconomics.

[54]  Oguzhan Alagoz,et al.  Incorporating Biological Natural History in Simulation Models: Empirical Estimates of the Progression of End-Stage Liver Disease , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[55]  Giovanni Parmigiani,et al.  The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions , 1997, Annals of Internal Medicine.

[56]  J D Habbema,et al.  The microsimulation approach to epidemiologic modeling of helminthic infections, with special reference to schistosomiasis. , 1996, The American journal of tropical medicine and hygiene.

[57]  Karen M Kuntz,et al.  Multiparameter calibration of a natural history model of cervical cancer. , 2007, American journal of epidemiology.

[58]  J. Savarino,et al.  Bayesian Calibration of Microsimulation Models , 2009, Journal of the American Statistical Association.

[59]  P. Walsh,et al.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2003, The Journal of urology.

[60]  J D Habbema,et al.  ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. , 1990, Computer methods and programs in biomedicine.

[61]  Milton C Weinstein,et al.  Empirically calibrated model of hepatitis C virus infection in the United States. , 2002, American journal of epidemiology.

[62]  J Koopman Models of Infectious Disease Agent Study , 2006 .

[63]  B. Manaster Cost-effectiveness of Bone Densitometry Followed by Treatment of Osteoporosis in Older Men , 2008 .

[64]  J. Toole,et al.  Development, validation, and application of a microsimulation model to predict stroke and mortality in medically managed asymptomatic patients with significant carotid artery stenosis. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[65]  C. Henschke,et al.  The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. , 2003, Chest.

[66]  Karl Claxton,et al.  Probabilistic analysis and computationally expensive models: Necessary and required? , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[67]  Constance F. Citro,et al.  Improving information for social policy decisions : the uses of microsimulation modeling , 1994 .

[68]  Deborah Schrag,et al.  How much can current interventions reduce colorectal cancer mortality in the U.S.? , 2006, Cancer.

[69]  J. Habbema,et al.  Cost-effectiveness of cervical cancer screening: comparison of screening policies. , 2002, Journal of the National Cancer Institute.

[70]  G Parmigiani,et al.  Measuring uncertainty in complex decision analysis models , 2002, Statistical methods in medical research.

[71]  Sue J Goldie,et al.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches. , 2008, PharmacoEconomics.

[72]  Eric Bonabeau,et al.  Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Lurdes Y. T. Inoue,et al.  Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. , 2006, Journal of the National Cancer Institute. Monographs.

[74]  M. Wolfson,et al.  POHEM--a framework for understanding and modelling the health of human populations. , 1994, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[75]  K E Willard,et al.  Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.

[76]  M. Rosenberg Chapter 3: Competing Risks to Breast Cancer Mortality , 2006 .

[77]  P. Glasziou,et al.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. , 1998, BMJ.

[78]  J. Berthelot,et al.  Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions. , 2001, European journal of cancer.

[79]  C. Ulrich,et al.  Does Folic Acid Supplementation Prevent or Promote Colorectal Cancer? Results from Model-Based Predictions , 2008, Cancer Epidemiology Biomarkers & Prevention.

[80]  K A Cronin,et al.  Assessing uncertainty in microsimulation modelling with application to cancer screening interventions. , 1998, Statistics in medicine.

[81]  Serge P. Hoogendoorn,et al.  State-of-the-art of vehicular traffic flow modelling , 2001 .

[82]  John Eng,et al.  Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. , 2003, JAMA.

[83]  C. Henschke Early lung cancer action project , 2000, Cancer.

[84]  Yen Lin Chia,et al.  Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration , 2004, Statistical methods in medical research.

[85]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[86]  Milton C Weinstein,et al.  Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[87]  M. Mcgrath Cost Effectiveness in Health and Medicine. , 1998 .

[88]  I. Longini,et al.  Simulation of mechanisms of viral interference in influenza. , 1990, International journal of epidemiology.

[89]  Geoff Delaney,et al.  The role of radiotherapy in cancer treatment , 2005, Cancer.

[90]  J. Bellsey,et al.  Healthcare applications of decision analytic modeling , 2000, HEPAC Health Economics in Prevention and Care.

[91]  B. McNeil,et al.  Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.

[92]  Carolyn Pillers Dobler,et al.  Mathematical Statistics , 2002 .

[93]  G. Koëter,et al.  Cost‐Effectiveness of Lung Transplantation in Relation to Type of End‐Stage Pulmonary Disease , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[94]  A Mark Fendrick The future of health economic modeling: have we gone too far or not far enough? , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[95]  K. Michaud,et al.  The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. , 2006, Archives of internal medicine.

[96]  Massimo Bernaschi,et al.  Optimization of HAART with genetic algorithms and agent-based models of HIV infection , 2007, Bioinform..

[97]  J. Yee,et al.  Accuracy of ct colonography for detection of large adenomas and cancers , 2009 .